AbolerIS Pharma Announces Formation of Scientific Advisory Board
GOSSELIES, Belgium and NANTES, France, April 24, 2025 /PRNewswire/ — AbolerIS Pharma (“AbolerIS”), a clinical-stage biopharmaceutical company committed to improving the lives of people suffering from autoimmune and inflammatory diseases, today …